Tinidazole: A classical anaerobical drug with multiple potential uses nowadays;Tinidazol: Un anaerobicida clásico con múltiples usos potenciales en la actualidad

Revista Espanola de Quimioterapia

Volumn 22, Issue 2, 2009, Pages 106-114

  Granizo Martinez, Juan José ^a   Rodicio, Ma Pía ^b   Manso, F J ^c   Giménez, Ma José ^d  

^a Grana Datos S L ^*  (Spain)

^b UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^c UNIVERSITY OF ALCALÁ   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Anaerobes; Helicobacter; Pharmacodynamia; Pharmacokinetics; Tinidazol

Indexed keywords

METRONIDAZOLE; TINIDAZOLE; ANTIINFECTIVE AGENT; ANTIPROTOZOAL AGENT;

ABDOMINAL SURGERY; AMEBIASIS; ANAEROBIC BACTERIUM; ANAEROBIC INFECTION; ANTIBIOTIC PROPHYLAXIS; DIABETIC FOOT; DRUG APPROVAL; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG STRUCTURE; ENTAMOEBA HISTOLYTICA; FOOD AND DRUG ADMINISTRATION; GIARDIA LAMBLIA; GIARDIASIS; HELICOBACTER INFECTION; HYSTERECTOMY; MALARIA; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PELVIC INFLAMMATORY DISEASE; REVIEW; TOOTH INFECTION; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; VAGINITIS; ANAEROBIC GROWTH; ANIMAL; CHEMISTRY; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLISM; PERIODONTITIS; POSTOPERATIVE COMPLICATION; PROTOZOON;

ANAEROBIOSIS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTIPROTOZOAL AGENTS; BACTERIA, ANAEROBIC; CLINICAL TRIALS AS TOPIC; ENTAMOEBIASIS; FEMALE; GIARDIASIS; HELICOBACTER INFECTIONS; HUMANS; MALE; PERIODONTITIS; POSTOPERATIVE COMPLICATIONS; PROTOZOA; TINIDAZOLE; TRICHOMONAS INFECTIONS; VAGINOSIS, BACTERIAL;

EID: 70349565962     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Scully BE. Metronidazole. Ann Clin North Am 1988;72:613-621
2. Fung HB, Doan T. Tinidazole: a Nitroimidazole Antiprotozoal Agent. Clin Ther 2005;27:1859-1884
3. Roberts SA, Shore KP, Paviour SD, Holland D, Morris AJ. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003. J Antimicrob Chemother 2006;57:992-998
4. Wybo I, Piérard D, Verschraegen I, et al. Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. J Antimicrob Chemother 2007;59:132-139 (Pubitemid 46017916)
5. Pankuch GA, Jacobs MR, Appelbaum PC. Susceptibilities of 428 gram-positive and-negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin. Antimicrob Agents Chemother 1993;37:1649-1654
6. Rees PH, McGlashan HE, Mwega V. Single dose treatment of vaginal trichomoniasis with tinidazole. East Afr Med J 1974;51:782-785
7. Nord CE. Microbiological properties of tinidazole: spectrum, activity and ecological considerations. J Antimicro Chemother 1982;10(Suppl.A):35-42.
8. Nord CE, Kager L. Tinidazole-microbiology, pharmacology and efficacy in anaerobic infections. Infection 1983;11:54-60.
9. Raether W, Hanel H. Nitroheterocyclic drugs with broad spectrum activity. Parasitol Res 2003;90 (Suppl. 1):S19-S39. (Pubitemid 36831290)
10. Tasca T, Borges FP, Bonan CD, De Carli GA, Battastini AM, Sarkis JJ. Effects of metronidazole and tinidazole on NTPDasa 1 and ecto 5′nucleotidase from intact cells of Trichomonas vaginalis. FEM Microbiol Lett 2003;226:379-384
11. Wiwanitkit V. Identification of weak points prone for mutation in ferredoxin of Trichomonas vaginalis. Indian J Med Microbiol 2008;26:158-159
12. Sears SD, O'Hare J. In vitro susceptibility of Trichomonas vaginalis to 50 antimicrobial agents. Antimicrob Agents Chemother 1988;32:144-146
13. Narcisi EM, Secor W. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis. Antimicrob Agents Chemother 1996;40:1121-1125
14. Schweke JR, Barrientes FJ. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother 2006;50:4209-4210
15. Chintana T, Sucharit P, Mahakittikun V, Siripanth C, Suphadtanaphongs W. In vitro studies on the sensitivity of local Entamoeba histolytica to anti-amoebic drug. Southeast Asian J Trop Med Publich Health 1986;17:591-594
16. Bansal D, Sehgal R, Chawla Y, Mahajan RC, Malla N. In vitro activity of antiamoebic drugs against clinical isolates of Entamoeba histolytica and Entamoeba dispar. Ann Clin Microbiol Antimicrob 2004;21:27-29
17. Gordts B, Hemelhof W, Asselmane C, et al. In vitro susceptibility of 25 Giardia lamblia isolates from human origin to six commonly used antiprotozoal agents. Antimicrob Agents Chemother 1985;28:378-380
18. Bergan T. Antibacterial activity and pharmacokinetics of nitroimidazoles: A review. Scand J Infect Dis Suppl 1985;46:64-71. (Pubitemid 16244189)
19. Jokipii AM, Jopikii L. Comparative activity of metronidazole and tinidazole against Clostridium difficile and Peptostreptococcus anaerobius. Antimicrob Agents Chemother 1987;31:183-186
20. Wood BA, Monro AM, Pharmacokinetics of tinidazole and metronidazole in women after single large single oral doses. Brit J Vener Dis 1975;51:51-53
21. Chaikin P, Alton KB, Sampson C, Weintraub HS. Pharmacokinetics of tinidazole in male and female subjets. J Clin Pharmacol 1982;22: 652-670 (Pubitemid 13170120)
22. Wood BA Faulkner JK, Monro MA. The pharmacokinetics, metabolism and tissue distribution of tinidazole. J Antimicrob Chemother 1982;10 (Suppl. A):43-57.
23. Ripa T, Westrom L, Mardh PA, Andersson KE. Concentrations of tinidazole in body fluids and tissues in gynaecological patients. Chemotherapy 1997;23:227-235
24. Viitanen J, Haataja H, Mannisto PT. Concentrations of metronidazole and tinidazole in male genital tissues. Antimicrob Agents Chemother 1985;28:812-814 (Pubitemid 16196920)
25. Von Konow L, Nord CE. Concentrations of tinidazole and metronidazole in serum, saliva and alveolar bone. J Antimicrob Chemother 1982;10(Suppl. A):165-172
26. Robson RA, Bailey RR, Sharman JR. Tinidazole pharmacokinetics in severe renal failure. Clin Pharmacokinet 1984;9:88-94. (Pubitemid 14175250)
27. Flouvat BL, Imbert C, Dobois DM et al. Pharmacokinetics of tinidazole in chronic renal failure and in patients on hemodialysis. Br J Clin Pharmacol 1983;15:735-741
28. Canut A. Antimicrobianos en las infecciones odontogénicas: análisis farmacocinético/farmacodinámico (PK/PD). Seguridad y tolerancia. En: Bascones A, Noguerol B, Prieto J, editores. Infecciones odontogénicas en la comunidad y antibioterapia: dos factores a sincronizar. Madrid: Adalia Farma/GETECCU, 2006; pp. 51-69.
29. Granizo JJ, Giménez MJ, Bascones A. Impacto ecológico del tratamiento antibiótico de las infecciones odontológicas. Rev Esp Quimioter 2006;19:14-20.
30. Mati JK, Wallace RJ. The treatment of trichomonal vaginitis using a single dose of tinidazole by mouth. East Afr Med J 1974;51:883-888
31. Apte W, Packard RS. Tinidazole in the treatment of trichomoniasis, giardiasis and amoebiasis. Report of a multicentre study. Drugs 1978;15(Suppl. 1):43-48
32. Gabriel G, Robertson E, Thin RN. Single dose treatment of trichomoniasis. J Int Med Res 1982;10:129-130
33. Aimakhu VE. Vaginal trichomoniasis: one stat dose of tinidazole compared with a seven-day course of metronidazole. West Afr Med J 1975;23:97-100.
34. O-Prasetawat P, Jetsawangrsi T. Split-dose metronidazole or single-dose tinidazole for the treatment of vaginal trichomoniasis. Sex Transm Dis 1992;19:295-297
35. Pépin J, Sobela F, Khonde N, Agyarko-Poku T, Soumaila D, Deslandes S, et al. The syndromic management of vaginal discharge using single-dose treatments: a randomized controlled trial in West Africa. Bull World Health Organ 2006;84:729-738
36. Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy for metronidazole resistant vaginal trichomoniasis.Clin Infect Dis 2001;33:1341-1346
37. Hager WD. Treatment of metronidazole resistant Trichomonas vaginalis with tinidazole. Case reports of three patients. Sex transm Dis 2004;31:343-345
38. Gazder AJ, Banerjee M. Single dose therapy of giardiasis with tinidazole and metronidazole. Drugs 1978;15(Suppl. 1):30-32 (Pubitemid 8341321)
39. Bakshi JS, Ghiara JM, Navidekar AD. How does tinidazole compare with metronidazole? A summary report of indian trials in amoebiasis and giardiasis. Drugs 1978;15(Suppl. 1):33-42.
40. Krishnamurty KA, Saradhambal V. Single dose therapy of giardiasis: A comparative study of tinidazole and metronidazole in pediatric patients. Indian Pediatr 1978;15:51-56 (Pubitemid 9124638)
41. Escobedo AA, Alvarez G, González ME, Almirall P, Cañete R, Cimerman S, et al. The teatment of giardiasis in children: single dose tinidazole compared with 3 days of nitazoxanide. Ann Trop Med Parasitol 2008;102:199-207.
42. Cañete R, Escobedo AA, González ME, Almirall P, Cantelar N. A randomized, controlled, open-label trial of a single day of mebendazole versus a single dose of tinidazole in the treatment of giardiasis in children. Curr Med Res Opin 2006;22:2131-2136 (Pubitemid 44789977)
43. Jokipii L, Jokipii AM. Single dose of metronidazole and tinidazole as therapy for giardiasis. Suiccess rates, side effects and drugs absortion and elimination. J Infect Dis 1979;140:984-988 (Pubitemid 10165141)
44. Speelman P. Single-dose tinidazole for the treatment of giardiasis. Antimicrob Agents Chemother 1985;27:227-229 (Pubitemid 15002436)
45. Nigam P, Kapoor KK, Kumar A, Sarkari NB, Gupta AK. Clinical profile of giardiasis and comparison of its therapeutic response to metronidazole and tinidazole. J Assoc Physicians India 1991;39:613-615
46. Kyronseppa H, Petterson T. Treatment of giardiasis: relative efficacy of metronidazole as compared with metronidazole. Scand J Infect Dis 1981;13:311-312
47. Islam N, Hasan M. Tinidazole in the treatment of intestinal amoebiasis. Curr Ther Res Clin Exp 1975;17:161-165
48. Misra NP, Gupta RC. A comparison of a short course of single daily dosage therapy of tinidazole with metronidazole in intestinal amoebiasis. J Int Med Res 1977;5:434-437 (Pubitemid 8220596)
49. Swami B, Lavakusulu D, Devi CS. Tinidazole and metronidazole in the treatment of intestinal amoebiasis. Curr Med Res Opin 1977;5:152-156 (Pubitemid 8225642)
50. Singh G, Kumar S. Short course of single daily dosage treatment with tinidazole and metronidazole in intestinal amoebiasis: a comparative study. Curr Med Res Opin 1977;5:157-160
51. Kundu SC, Bhattacherjee TD, Dasgupta DP, Dasgupta DP, Majumdar S, Moorkerjee PK, et al. Comparative evaluation of tinidazole ans metronidazole in the treatment of amoebic liver abscess. J Indian Med Assoc 1977;69:127-129 (Pubitemid 8262430)
52. Simjee AE, GathiramV, Jackson TF, Khan BF. A comparative trial of metronidazole versus tinidazole in the treatment of amoebic liver abscess. S Afr Med J 1985;68:923-924
53. Mohanty KC, Deighton R. Comparison of 2 g single dose of metronidazole, nimorazole and tinidazole in the treatment of vaginitis associated with Gardenella vaginalis. J Antimicrob Chemother 1987;19:393-399
54. Nailor MD, Sobel JD. Tinidazole for bacterial vaginosis. Expert Rev Anti Infect Ther 2007;5:343-348
55. Livengood CH, Ferris DG, Wiesenfeld HC, Hillier SL, Soper DE, Niyrjesy P, et al. Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: a randomized controlled trial. Obstet Gynecol 2007;110:302-309
56. Manes G, Balzano A. Tinidazole: from protozoa to Helicobacter pylori - The past, present and future of a nitroimidazole with peculiarities. Expert Rev Anti Infect Ther 2004;2:695-705.
57. Dhar KK, Dhal GL, Ayyagari A. Tinidazole prophylaxis in elective abdominal hysterectomy. Int J Gynecol Obstet 1993;42:121-125. (Pubitemid 23238981)
58. Cocks PS. Prophylactic tinidazole for hysterectomy-experience of 870 cases during 1980 and 1981. J Antimicrob Chemother 1982;10(Suppl. A):85-86
59. Dahr KK, Dahl GL, Ayyagari A. Single dose of tinidazole prophylaxis in vaginal hysterectomy. Int J Gynecol Obstet 1993;42:117-120. (Pubitemid 23238980)
60. Joshi S, Maroli S, Moulick ND, Badhane S, Sthalekar N, Ambavane V, et al. Efficacy and tolerability of a combination of ofloxacin and tinidazole in the management of infectious diabetic foot ulcer. J Indian Med Assoc 2003;101:329-332 (Pubitemid 37237120)
61. Malhotra M, Sharma JB, Batra S, Arora R, Sharma S. Ciprofloxacin- tinidazole combination, fluconazole-azithromycin-secnidazole kit and doxycycline-metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial. Indian J Med Sci 2003;57:549-555
62. Manso F, Gamboa MS, Giménez MJ, Bascones A, Gómez-Lus ML, Aguilar L. Why not revisiting tinidazole as potential treatment of odontogenic infections? Rev Esp Quimioter 2008;21:198-202.
63. Alou L, Giménez MJ, Manso F, Sevillano D, Torrico M, González N, et al. Tinidazole inhibitory and tidal activity against anaerobic periodontal pathogens. Int J Antimicrob Agents 2009;33:449-452
64. Gallardo F, Huerta J, Cruz E, et al. Efectos de tinidazol en el tratamiento de la enfermedad periodontal del adulto. Av Period Impl 1994;6:161-174
65. a reunión anual de la Sociedad Española de Odontología Integrada en adultos (Madrid, 8-9 mayo 2009), comunicación oral no. 2, p. 24.
66. Graham. DY, Lu H, Yamaoka Y. Therapy for Helicobacter pylori. Drugs 2008;68:725-736
67. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, et al. Current concepts in the management of Helicobacter pylori infection. The Maastricht 2-2000 Consensus Report. European Helicobacter Study Group (EHPSG). Aliment Pharmacol Ther 2002;16:167-180
68. Howden CW, Hunt RH. Guidelines for the management of Helicobacter pylori infections. The ad hoc Committee on Practice Parameters of the American College of Gastroentorology. Am J Gastroenterol 1998;93:2330-2338
69. Laheij RL, Rossum LG, Jansen JB, Straatman H, Verbeek AL. Evaluation of treatment regimens to cure Helicobacter pylori infection - a meta-analysis. Aliment Pharmacol Ther 1999;13:857-864
70. Sarma PSA. Tinidazole: a new drug in the treatment of vivax malaria. Curr Ther Res Clin Exp 1988;43: 954-956
71. www.vademecum.es/principios-activos/ficha/J01XD02. Consultado el 15 de diciembre de 2008.
72. Czeizel AE; Kazy Z, Vargha P. Oral tinidazole treatment during pregnancy and teratogenesis. Int J Gynaecol Obstet 2003;83:305-306 (Pubitemid 37468438)